231 related articles for article (PubMed ID: 33680928)
1. Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.
Xing B; Guo J; Sheng Y; Wu G; Zhao Y
Front Oncol; 2020; 10():606335. PubMed ID: 33680928
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers.
Yoshida H; Shiraishi K; Kato T
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944973
[TBL] [Abstract][Full Text] [Related]
3. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract][Full Text] [Related]
4. Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers.
Arroyo Mühr LS; Lagheden C; Eklund C; Lei J; Nordqvist-Kleppe S; Sparén P; Sundström K; Dillner J
J Gen Virol; 2020 Mar; 101(3):265-270. PubMed ID: 31859615
[No Abstract] [Full Text] [Related]
5. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
[TBL] [Abstract][Full Text] [Related]
6. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
8. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
9. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
10. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
11. How Does Infection with Human Papillomavirus 16 and 18 Impact on DNA Damage and Repair in Cervical Cells and Peripheral Blood?
Ozcagli E; Biri A; Dinc B; Sardas S
OMICS; 2018 May; 22(5):332-336. PubMed ID: 29708858
[TBL] [Abstract][Full Text] [Related]
12. Cervical atypical glandular cells and false negative HPV testing: a dramatic reality of the wrong test at the right place.
Tjalma WA; Depuydt CE
Eur J Gynaecol Oncol; 2014; 35(2):117-20. PubMed ID: 24772911
[TBL] [Abstract][Full Text] [Related]
13. The negative conversion of high-risk human papillomavirus and its performance in surveillance of cervical cancer after treatment: a retrospective study.
Song D; Kong WM; Zhang TQ; Jiao SM; Chen J; Han C; Liu TT
Arch Gynecol Obstet; 2017 Jan; 295(1):197-203. PubMed ID: 27619686
[TBL] [Abstract][Full Text] [Related]
14. HPV-Negative Cervical Cancer: A Narrative Review.
Arezzo F; Cormio G; Loizzi V; Cazzato G; Cataldo V; Lombardi C; Ingravallo G; Resta L; Cicinelli E
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34073478
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract][Full Text] [Related]
17. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus testing in patients with invasive cervical carcinoma: An institutional experience.
Can NT; Tesic V; Antic T
J Am Soc Cytopathol; 2014; 3(3):126-130. PubMed ID: 31051735
[TBL] [Abstract][Full Text] [Related]
19. HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.
Mkrtchian L; Zamulaeva I; Krikunova L; Kiseleva V; Matchuk O; Liubina L; Kulieva G; Ivanov S; Kaprin A
J Pers Med; 2021 May; 11(6):. PubMed ID: 34071821
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
